Study of the CDK4/6 Inhibitor Palbociclib (PD-0332991) in Combination With the PI3K/mTOR Inhibitor Gedatolisib (PF-05212384) for Patients With Advanced Squamous Cell Lung, Pancreatic, Head & Neck and Other Solid Tumors
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
ProgenaBiome
Cancer Research UK
The Clatterbridge Cancer Centre NHS Foundation Trust
Hospital General Universitario Gregorio Marañon
Roger Williams Medical Center
Envita Medical Center, Inc.